Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I clinical and pharmacokinetic study of zeniplatin, a new platinum complex.
Dodion PF, de Valeriola D, Crespeigne N, Kantrowitz JD, Piccart M, Wery F, Kerger J, Egorin MJ, Forrest A, Bachur NR, et al. Dodion PF, et al. Among authors: kerger j. Ann Oncol. 1991 Sep;2(8):589-96. doi: 10.1093/oxfordjournals.annonc.a058026. Ann Oncol. 1991. PMID: 1793726 Free article. Clinical Trial.
Tumour stimulating effects of recombinant human interleukin-6.
Ravoet C, DeGrève J, Vandewoude K, Kerger J, Sculier JP, Lacor P, Stryckmans P, Piccart M. Ravoet C, et al. Among authors: kerger j. Lancet. 1994 Dec 3;344(8936):1576-7. doi: 10.1016/s0140-6736(94)90387-5. Lancet. 1994. PMID: 7983975 Clinical Trial. No abstract available.
A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors.
Van Den Neste E, de Valeriola D, Kerger J, Bleiberg H, Kusenda Z, Brassinne C, Bartholomeus S, Selleslags J, Hennebert P, Wythouck H, Cazenave I, Lefresne-Soulas F, Piccart M. Van Den Neste E, et al. Among authors: kerger j. Clin Cancer Res. 2000 Jan;6(1):64-71. Clin Cancer Res. 2000. PMID: 10656433 Clinical Trial.
Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer.
Piccart MJ, Di Leo A, Beauduin M, Vindevoghel A, Michel J, Focan C, Tagnon A, Ries F, Gobert P, Finet C, Closon-Dejardin MT, Dufrane JP, Kerger J, Liebens F, Beauvois S, Bartholomeus S, Dolci S, Lobelle JP, Paesmans M, Nogaret JM. Piccart MJ, et al. Among authors: kerger j. J Clin Oncol. 2001 Jun 15;19(12):3103-10. doi: 10.1200/JCO.2001.19.12.3103. J Clin Oncol. 2001. PMID: 11408507 Clinical Trial.
65 results